The Use of Demoralization Scale in Italian Kidney Transplant Recipients.
demoralization
kidney transplantation
psychiatric morbidity
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
05 Jul 2020
05 Jul 2020
Historique:
received:
23
05
2020
revised:
02
07
2020
accepted:
03
07
2020
entrez:
9
7
2020
pubmed:
9
7
2020
medline:
9
7
2020
Statut:
epublish
Résumé
Demoralization is a commonly observed syndrome in medically ill patients. The risk of demoralization may increase in patients after a kidney transplant (KTRs) because of the stressful nature of renal transplantation, psychosocial challenges, and adjustment needs. No study is available on demoralization amongst KTRs. The purpose of our study was to evaluate the validity of the Italian version of the Demoralization Scale (DS-IT) and the prevalence of demoralization in KTRs. Also, we aimed at exploring the association of the DS-IT with International Classification of Diseases (ICD) psychiatric diagnoses, post-traumatic growth (PTG), psychological and physical symptoms, and daily-life problems. A total of 134 KTRs were administered the MINI International Neuropsychiatric Interview 6.0. and the Diagnostic Criteria for Psychosomatic Research-Demoralization (DCPR/D) Interview. The DS-IT, the Edmonton Symptom Assessment System (ESAS), the Canadian Problem Checklist (CPC), were used to measure demoralization, physical and psychological symptoms, and daily-life problems; also, positive psychological experience of kidney transplantation was assessed with the PTG Inventory. Routine biochemistry and sociodemographic data were collected. Exploratory factor analysis demonstrated a four-dimensional factor structure of the DS-IT, explaining 55% of the variance (loss of meaning and purpose, disheartenment, dysphoria, and sense of failure). DS-IT Cronbach alpha coefficients indicated good or acceptable level of internal consistency. The area under the Receiving Operating Characteristics (ROC) curve for DS-IT (against the DCPR/D interview as a gold standard) was 0.92. The DS-IT optimal cut-off points were ≥20 (sensitivity 0.87, specificity 0.82). By examining the level of demoralization, 14.2%, 46.3%, 24.6%, and 14.6% of our sample were classified as having no, low, moderate, and high demoralization, respectively, with differences according to the ICD psychiatric diagnoses (
Identifiants
pubmed: 32635625
pii: jcm9072119
doi: 10.3390/jcm9072119
pmc: PMC7408932
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Support Care Cancer. 2006 Jan;14(1):30-7
pubmed: 15937688
Psychosomatics. 2004 Nov-Dec;45(6):483-91
pubmed: 15546825
Palliat Med. 2002 Jul;16(4):339-45
pubmed: 12132547
J Pain Symptom Manage. 2015 Mar;49(3):595-610
pubmed: 25131888
Clin Nephrol. 2020 Feb;93(2):57-64
pubmed: 31319906
Compr Psychiatry. 1993 Sep-Oct;34(5):308-11
pubmed: 8306640
Transplantation. 2014 Apr 15;97(7):717-21
pubmed: 24342977
J Clin Psychiatry. 1998;59 Suppl 20:22-33;quiz 34-57
pubmed: 9881538
Psychol Med. 2015 Mar;45(4):673-91
pubmed: 25032712
Psychosom Med. 2010 Jul;72(6):527-34
pubmed: 20410250
J Trauma Stress. 1996 Jul;9(3):455-71
pubmed: 8827649
Psychooncology. 2014 Mar;23(3):283-90
pubmed: 24123321
Psychooncology. 2017 Nov;26(11):1965-1971
pubmed: 28263003
Eur J Cardiovasc Nurs. 2019 Feb;18(2):149-162
pubmed: 30226074
Psychol Med. 2012 Feb;42(2):401-7
pubmed: 24438853
Psychother Psychosom. 2015;84(5):265-72
pubmed: 26278129
Biom J. 2008 Jun;50(3):419-30
pubmed: 18435502
J Psychiatr Res. 2016 Jun;77:42-51
pubmed: 26978184
Kidney Blood Press Res. 2014;39(2-3):189-96
pubmed: 25118037
J Palliat Care. 2004 Winter;20(4):269-76
pubmed: 15690829
J Behav Med. 2001 Dec;24(6):561-71
pubmed: 11778350
Cancer. 2016 Jul 15;122(14):2260-7
pubmed: 27171544
Br J Psychiatry. 2013 Feb;202:100-7
pubmed: 23377209
Curr Oncol. 2007 Oct;14(5):180-8
pubmed: 17938701
J Pain Symptom Manage. 2017 Feb;53(2):243-249
pubmed: 27744017
J Nephrol. 2015 Apr;28(2):143-50
pubmed: 25644550
J Pain Symptom Manage. 2015 May;49(5):945-52
pubmed: 25523890
J Pain Symptom Manage. 2017 Mar;53(3):630-643
pubmed: 28042071
JMIR Med Inform. 2018 Oct 22;6(4):e46
pubmed: 30348634
PLoS One. 2015 Nov 11;10(11):e0140706
pubmed: 26559531
Support Care Cancer. 2014 Dec;22(12):3165-74
pubmed: 24935648
Kidney Int. 2010 Feb;77(4):299-311
pubmed: 19847156
Cancer. 2016 Jul 15;122(14):2130-3
pubmed: 27171755
J Clin Med. 2020 Apr 02;9(4):
pubmed: 32252326
J Clin Psychiatry. 2011 May;72(5):648-54
pubmed: 21208590
J Affect Disord. 2020 Sep 1;274:568-575
pubmed: 32663989
Psychother Psychosom. 2005;74(2):100-7
pubmed: 15741759
J Pain Symptom Manage. 2011 Nov;42(5):768-76
pubmed: 21592722
J Palliat Care. 2001 Spring;17(1):12-21
pubmed: 11324179
J Renal Inj Prev. 2013 Nov 03;3(1):27-30
pubmed: 25340160
Palliat Support Care. 2015 Oct;13(5):1449-58
pubmed: 25739745
Psychother Psychosom. 2009;78(6):342-5
pubmed: 19713728
J Neurol. 2020 Apr;267(4):966-974
pubmed: 31802218
Aust N Z J Psychiatry. 2002 Dec;36(6):733-42
pubmed: 12406115
World Psychiatry. 2005 Jun;4(2):96-105
pubmed: 16633525
J Psychosom Res. 2020 Jan;128:109889
pubmed: 31812103
Cancer. 2017 Sep 1;123(17):3394-3401
pubmed: 28472548
Palliat Support Care. 2009 Sep;7(3):323-30
pubmed: 19788774
Psychooncology. 2018 Nov;27(11):2616-2622
pubmed: 29943491
J Affect Disord. 2007 Aug;101(1-3):251-4
pubmed: 17196662
J Clin Psychiatry. 2005 Mar;66(3):391-4
pubmed: 15766307
Psychol Health Med. 2014;19(6):650-5
pubmed: 24479466
Psychother Psychosom. 2018;87(6):375-376
pubmed: 30391961